Faron Pharmaceuticals Oy: Initial positive data from Phase 2 of BEXMAB arvopaperi.fi - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arvopaperi.fi Daily Mail and Mail on Sunday newspapers.
Arecor Therapeutics plc AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN DEMONSTRATES SUPERIORITY IN PHASE I CLINICAL TRIAL IN OVERWEIGHT AND OBESE PEOPLE WITH TYPE 2 DIABETES AT278 demonstrates.